Navigation Links
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
Date:8/19/2007

PETACH-TIKVA, Israel, August 16 /PRNewswire-FirstCall/ -- Healthcare Technologies Ltd. (NASDAQ: HCTL), today announced unaudited results for the second quarter and six months period ended June 30, 2007.

Revenues for the first six months of 2007 were $7.75 million, compared to $7.05 million for the first six months of 2006. The gross profit for the first half of the year was $2.43 million versus $2.57 million for the same period in 2006. The net loss for such period was $(319) thousand, versus a net profit of $523 thousand for the first half of 2006.

Revenues for the second quarter of 2007 were $3.67 million, as compared to $3.46 million for the corresponding quarter last year. The second quarter gross profit was $1.08 million, as compared to $1.18 million in the second quarter of 2006. The net loss for the second quarter was $(432) thousand, compared to a net profit of $171 thousand for the second quarter of last year. Healthcare's loss in Q2 2007 is mainly due to the following: (i) a decrease of approximately $300 thousand in sales to the clinical diagnostics market vs. the first quarter; (ii) financial expenses relating to the depreciation of the NIS versus the US dollar; and (iii) one time legal settlement expenses amounting to approximately $155 thousand. The net loss was decreased by the creation of deferred tax income amounting to $119 thousand, which was recorded by the company.

Shareholders' equity on June 30, 2007 was $6.9 million, compared to $7.3 million on December 31, 2006. Current assets net of current liabilities at the end of the period were $1.5 million, compared to $2.6 million on December 31, 2006.

About Healthcare Technologies

Healthcare Technologies Ltd. through it su
'/>"/>

SOURCE Healthcare Technologies Ltd

Copyright©2007 PR Newswire.

Page: 1 2 3

Related biology technology :

1. Web-based reporting credited with states top healthcare ranking
2. Visions: Preizler offers insurers perspective on healthcare IT
3. Federal bill would set healthcare IT standards
4. IRS ruling could speed healthcare technology adoption
5. Bill would provide federal aid for healthcare IT
6. DHC 2007: Hayden says technology creates magic moment for healthcare delivery
7. Digital Healthcare Conference 2007: Mounting obstacles for health IT
8. Georgia healthcare system to install GEs radio frequency ID
9. GE Healthcare leads compact ultrasound market
10. CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare
11. Merge Healthcare suffers $258M loss in `06

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Nov. 6 Intarcia Therapeutics, In...50 (DUROS® continuous delivery of exenatide) ...e Ninth Annual Diabetes Technology Meeting in San ...m/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Cont... 650 Lowers Plasma Glucose, HbA1c and Reduces Weig...
(Date:11/5/2009)...- Gone hybrid . . . , Fuel economy ratings for...d at the www.fueleconomy.gov web site, which Oak... for the U.S. Department of Energy and the U.S. En...vehicles on the best fuel economy list are hybrid ...8 highway). "This list proves that hybrids have go...
(Date:11/5/2009)...o., Nov. 5 The endangered black-fo...ern U.S. This rare carnivore feeds on prairie dog...ue and often entire population die-offs in towns o...has implemented a ferret breeding program and has ... formerly native habitat. Unfortunately, plague c...
(Date:11/5/2009)... 5 Imagenetix, Inc. (OTC...am Spencer, President and CEO of Imagenetix, will ...l LD MICRO Conference on Thursday, December 3rd, a...,, About LD MICRO ,, LD MICRO is a by-invita...undervalued companies in the micro-cap space. Sinc...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...ensive and,coherent corporate brand and positionin...place is a critical step to developing a pipeline ..., developing, retaining and,engaging top talent du...top,of mind for executives across the country toda...rategic HR topics at the,10th Annual Human Resourc...
...d tropic HIV patients with sa... Pathway Diagnostics announces,nationwide availabi...ensiTrop(TM) II assay, combining the sensitivity o...nology with the specificity of molecular,sequencin...f HIV infected,patients. Pathway performs the Sens...
..., May 7, 2008 at 10:00 AM EDT, CEDAR KNOLLS, N.J....IS ) today announced its financial results for,the...ill host a conference call to discuss first quarte...A live Webcast of the conference,call can be acces....emisphere.com .,The live conference call dial-in ...
Other Biology Technology:Group Hotel Rate Ends Friday: Reserve Now for Leadership Development Conference June 4-6 2Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay 2Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 2Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 3Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 4Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 5Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 6Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results 7
(Date:11/4/2009)... (top news in natural science) , United States...s less water today than it did 35 years ago, despi...ater use are partly attributable to alternative co...rrigation systems. According to the latest USGS wa...he United States goes to cooling thermoelectric po...
(Date:11/4/2009)..., MO, November 4, 2009 Childhood obesity in the U...h more than one fourth of advertising on daytime a...rages and continuing questions about the role tele...ecember issue of the Journal of Nutrition Educati...ed at children might be a large contributor to the...
(Date:11/4/2009)...pore laboratory that deciphered the DNA codes, or ...phant shark, has joined The Genome 10K Project, an...itory of DNA sequences on 10,000 species of animal...at currently can not be achieved. , Participatin...published in the Nov. 5, 2009 issue of the Journa...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Singapore scientists join international study of 10,000 vertebrates' genomes 2Forest Laboratories Announces Positive Top line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community acquired Bacteria 49495 1Forest Laboratories Announces Positive Top line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community acquired Bacteria 49495 2Forest Laboratories Announces Positive Top line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community acquired Bacteria 49495 3Forest Laboratories Announces Positive Top line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community acquired Bacteria 49495 4Forest Laboratories Announces Positive Top line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community acquired Bacteria 49495 5GEN reports on alternative feedstocks for ethanol production 8929 1Athletes spectators faced unprecedented air pollution at 2008 Olympic Games 8927 1Athletes spectators faced unprecedented air pollution at 2008 Olympic Games 8927 2Athletes spectators faced unprecedented air pollution at 2008 Olympic Games 8927 3
...lif. A research team led by Mark Hoddle , a biol...rly eradicated the glassy-winged sharpshooter , a...i and several other French Polynesian islands in t...ression, the researchers used biological control, ...rol and can be applied to areas where the sharpsho...
...Ill., March 13, 2008 Data published today in The ...l of a fully bioabsorbable drug eluting stent for ...ated no stent thrombosis, no clinically driven tar...iseased lesion), and a low (3.3 percent) rate of m...out to one year. These one year results for Abbott...
...tention deficit hyperactivity disorder stand a sub...ders in adolescence than girls without ADHD, a new...requently develop body-image dissatisfaction and m... purging behaviors that are common in bulimia nerv...ri Yee Mikami, who led the study. , The findings ...
Other Biology News:UCR-led research team uses tiny wasp to wipe out major agricultural pest in Tahiti 2UCR-led research team uses tiny wasp to wipe out major agricultural pest in Tahiti 3UCR-led research team uses tiny wasp to wipe out major agricultural pest in Tahiti 4The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent 2Adolescent girls with ADHD are at increased risk for eating disorders, study shows 2
ICC Diluent Buffer from BD Biosciences Pharmingen
Anti-J Chain Monoclonal Antibody, Unconjugated, Clone M19/9J from CHEMICON
ZOOM® IEF Fractionator from Invitrogen
Tissue Stat from Biomeda Corporation
Biology Products: